Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Injections × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 35 Breast Neoplasms 17 Advanced Solid Tumors 16 Myelodysplastic Syndromes 14 Advanced Solid Tumor 11 Recurrence 9 Carcinoma, Non-Small-Cell Lung 9 Leukemia, Myelomonocytic, Chronic 8 Neoplasms 7 Myeloproliferative Disorders 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Triple Negative Breast Neoplasms 5 Solid Tumor 5 Ovarian Neoplasms 5 Advanced Solid Tumour 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Lymphoma, B-Cell 4 Lung Neoplasms 4 Carcinoma, Hepatocellular 4 Advanced Malignant Solid Tumor 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Prostatic Neoplasms 3 Primary Myelofibrosis 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Myelodysplastic-Myeloproliferative Diseases 3

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 8 Nivolumab 8 Carboplatin 7 Ipilimumab 5 Cyclophosphamide 5 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Gemcitabine 3 Drug Therapy 3 tremelimumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Methotrexate 2 Interleukin-2 2 Chemotherapy, Adjuvant 2 sargramostim 1 olaparib 1 niraparib 1 nintedanib 1 methoxyamine 1 lenvatinib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡